VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
NUTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksNUTXInstitutional Holders

NUTX logoNutex Health, Inc. (NUTX) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+2.64 pp), though top 10 holders maintain a highly concentrated 65.3% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
42.7%$491M total value · ▲ +2.64 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
66 / 100Bullish
Institutions & Flow154 holders+22 net flow (+35 / -13)

AI Insights & Key Takeaways

  • Positive Institutional Flow (+22)
  • Millennium Management Llc maintains a significant position
  • Top 10 holders control 65.3% of institutional value
  • No Insider Signal

Top Institutional Holders of NUTX

Ranked by reported Q2 2026 13F market value

Top 10 Holders
65.3%
Top 25 Holders
84.1%

Share of total reported institutional value in NUTX held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1Pertento Partners LLP451K$77.1M+20.7%6.559%4.16%
2BlackRock, Inc.407K$69.6M+7.4%5.920%0.00%
3AMERICAN CENTURY COMPANIES INC237K$40.6M+16.7%3.450%0.02%

Quarterly Institutional Activity

Filings activity in NUTX during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers35Added To105Trimmed11Exited13
  • D. E. Shaw & Co., Inc.$16.7M
  • Focus Partners Wealth$10.4M
  • CITADEL ADVISORS LLC

NUTX Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026154+18%42.71%+2.64 pp$491M+89%
Q1 2026131+15%40.07%+2.74 pp$260M39%
Q4 2025114+21%37.33%+2.61 pp$423M+70%
Q3 2025946.0%34.72%+8.64 pp$248M+18%
Q2 2025100+122%26.08%+8.63 pp$210M+366%
Q1 202545+13%

How NUTX Compares to Peers

Institutional ownership and quarterly buying activity across the largest Healthcare Providers peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
STLNStarling Oncology, Inc.$362M43.0%119+4
ACHAccendra Health, Inc.$16M83.0%141-3

NUTX — Frequently Asked Questions

Quick answers to the most common questions about buying NUTX stock.

What percentage of NUTX is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Nutex Health, Inc. stands at 42.7%, held across 154 reporting institutions.

Who is the largest institutional holder of NUTX?

Pertento Partners LLP is the largest reported institutional holder of NUTX, with approximately 451,310 shares worth $0.08B as of Q2 2026.

Is NUTX a hedge fund favorite?

Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of NUTX, including MILLENNIUM MANAGEMENT LLC.

What is NUTX's Smart Money Score?

Our composite Smart Money Score for NUTX is 66 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought NUTX this quarter?

35 institutions opened new positions in NUTX during Q2 2026, while 13 fully exited. 105 added to existing positions and 11 trimmed.

4VANGUARD CAPITAL MANAGEMENT LLC216K$36.9M-1.5%3.138%0.00%
5GEODE CAPITAL MANAGEMENT, LLC132K$22.6M+8.1%1.919%0.00%
6STATE STREET CORP131K$22.4M+6.2%1.901%0.00%
7D. E. Shaw & Co., Inc.97K$16.7M—1.416%0.01%
8UBS Group AG78K$13.3M+12.0%1.132%0.00%
9WINMILL & CO. INC65K$11.2M0.0%0.950%2.47%
10Focus Partners Wealth61K$10.4M—0.885%0.01%
11MILLENNIUM MANAGEMENT LLC52K$8.9M-41.8%0.757%0.00%
12GOLDMAN SACHS GROUP INC51K$8.8M+51.6%0.745%0.00%
13BRIDGEWAY CAPITAL MANAGEMENT, LLC47K$8.0M+212.4%0.682%0.14%
14Empowered Funds, LLC45K$7.7M+39.2%0.656%0.04%
15NORTHERN TRUST CORP44K$7.5M+6.8%0.640%0.00%
16Topline Capital Management, LLC42K$7.1M-76.5%0.607%1.85%
17ONE PLUS ONE WEALTH MANAGEMENT, LLC40K$6.9M0.0%0.588%2.98%
18VANGUARD FIDUCIARY TRUST CO36K$6.1M+0.4%0.523%0.00%
19VANGUARD PORTFOLIO MANAGEMENT LLC35K$5.9M-12.9%0.504%0.00%
20VICTORY CAPITAL MANAGEMENT INC29K$5.0M-35.3%0.424%0.00%
21TRUIST FINANCIAL CORP27K$4.6M+1.9%0.390%0.01%
22LOS ANGELES CAPITAL MANAGEMENT LLC25K$4.3M-21.6%0.365%0.02%
23Bank of New York Mellon Corp23K$4.0M+7.1%0.336%0.00%
24BARCLAYS PLC22K$3.8M+25.7%0.327%0.00%
25JPMORGAN CHASE & CO20K$3.4M-2.2%0.291%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in NUTX — a direct measure of their conviction.

$3.1M
  • SIERRA SUMMIT ADVISORS LLC$1.6M
  • Y-Intercept (Hong Kong) Ltd$602K
  • Gotham Asset Management, LLC$557K
  • ALLIANCEBERNSTEIN L.P.$485K
  • Farther Finance Advisors, LLC$484K
  • Quadrature Capital Ltd$430K
  • Amundi$378K
  • Caprock Group, LLC$370K
  • Plan Group Financial, LLC$282K
  • 17.45%
    +2.42 pp
    $45M
    +71%
    Q4 202440+43%15.03%+6.71 pp$26M+178%
    Q3 202428—8.32%—$9M—

    Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

    How is institutional ownership of NUTX changing?

    NUTX institutional ownership rose by 2.64 percentage points quarter-over-quarter, with a net change of +23 holders.

    How concentrated is NUTX ownership among the top holders?

    The top 10 institutions account for 65.3% of all reported 13F value in NUTX, and the top 25 account for 84.1%.

    How does NUTX compare to Healthcare Providers on institutional ownership?

    Across the largest Healthcare Providers peers, institutional ownership levels are: STLN (43.0%), ACH (83.0%). See the peer comparison table on this page for net buyer activity by company.

    Where does this NUTX institutional ownership data come from?

    All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

    NUTXNutex Health, Inc.
    $172.74$1.2B
    Overview & Tools
    OverviewChart Terminal ↗Visualize
    Valuation & Forecasts
    Valuation ModelsEstimatesDCF Model
    Price & Analyst Data
    Analyst TargetsPrice History
    Financial Statements
    Income StatementBalance SheetCash FlowRatios & Margins
    Performance
    P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
    Discovery & Screens
    Live BreakoutsStock ScreenerOwnership